脑部放疗，上午比下午敏感许多！# l' D0 a% A! c0 }# c
3 A2 f' M( q# E( }
0 D! R( e {4 b# _Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
: G4 H- P7 h+ d! c+ @+ H/ I/ UGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?5 c8 t* Y9 h% o. [1 [
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.+ n4 p2 Y- w1 U+ H1 D7 I
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
, ]$ U$ s) G8 x7 z( }5 i$ a6 Q
8 {, ~1 S3 @% z7 X* a/ L. fAbstract
, e8 T* f! \2 j8 L) \+ \) }BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time., \3 K9 e" z9 y% q, P9 `
; ^% u1 H- D6 X$ R' YMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.5 N! I2 N$ ~/ Q6 X
: b; ` I) p. f7 G7 E+ ]6 h r
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).6 R* T5 N9 J' E" K' k
3 z6 K. J& L1 ?CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
- l8 h. r! k! S: T& B2 x* |, b! S. G; r7 U P" A# z: A
|
显身卡
